These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 8804339)

  • 21. [A model of congenital erythropoietic porphyria for gene transfer in hematopoietic cells].
    de Verneuil H; Moreau-Gaudry F; Ged C
    Transfus Clin Biol; 1997; 4(3):263-6. PubMed ID: 9264783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Congenital erythropoietic porphyria: dilemmas in present day management.
    Dawe SA; Peters TJ; Du Vivier A; Creamer JD
    Clin Exp Dermatol; 2002 Nov; 27(8):680-3. PubMed ID: 12472546
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Successful gene therapy of mice with congenital erythropoietic porphyria].
    de Verneuil H; Robert-Richard E; Ged C; Mazurier F; Richard E; Moreau-Gaudry F
    Med Sci (Paris); 2008; 24(6-7):615-20. PubMed ID: 18601879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Congenital erythropoietic porphyria: advances in pathogenesis and treatment.
    Desnick RJ; Astrin KH
    Br J Haematol; 2002 Jun; 117(4):779-95. PubMed ID: 12060112
    [No Abstract]   [Full Text] [Related]  

  • 25. [Congenital erythropoietic porphyria].
    Kondo M; Yano Y
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):152-4. PubMed ID: 9645030
    [No Abstract]   [Full Text] [Related]  

  • 26. Report of a novel Indian case of congenital erythropoietic porphyria and overview of therapeutic options.
    Pandey M; Mukherjee SB; Patra B; Kapoor S; Ged C; Aneja S; Seth A
    J Pediatr Hematol Oncol; 2013 May; 35(4):e167-70. PubMed ID: 23612387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acquired erythropoietic uroporphyria secondary to myelodysplastic syndrome with chromosome 3 alterations: a case report.
    Podlipnik S; Guijarro F; Combalia A; To-Figueras J; Badenas C; Costa D; Rozman M; Jorge S; Aguilera P; Gaya A
    Br J Dermatol; 2018 Aug; 179(2):486-490. PubMed ID: 28865079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Erythropoietic porphyrias: animal models and update in gene-based therapies.
    Richard E; Robert-Richard E; Ged C; Moreau-Gaudry F; de Verneuil H
    Curr Gene Ther; 2008 Jun; 8(3):176-86. PubMed ID: 18537592
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular genetics of congenital erythropoietic porphyria.
    Desnick RJ; Glass IA; Xu W; Solis C; Astrin KH
    Semin Liver Dis; 1998; 18(1):77-84. PubMed ID: 9516681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A knock-in mouse model of congenital erythropoietic porphyria.
    Ged C; Mendez M; Robert E; Lalanne M; Lamrissi-Garcia I; Costet P; Daniel JY; Dubus P; Mazurier F; Moreau-Gaudry F; de Verneuil H
    Genomics; 2006 Jan; 87(1):84-92. PubMed ID: 16314073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neonatal hemolytic anemia does not always indicate thalassemia: a case report.
    Al-Harazi AA; Al-Eryani BM; Al-Sharafi BA
    BMC Res Notes; 2017 Sep; 10(1):476. PubMed ID: 28899405
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correction of deficient CD34+ cells from peripheral blood after mobilization in a patient with congenital erythropoietic porphyria.
    Mazurier F; Géronimi F; Lamrissi-Garcia I; Morel C; Richard E; Ged C; Fontanellas A; Moreau-Gaudry F; Morey M; de Verneuil H
    Mol Ther; 2001 Mar; 3(3):411-7. PubMed ID: 11273784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Congenital erythropoietic porphyria with erythrodontia: A case report.
    Ciftci V; Kılavuz S; Bulut FD; Mungan HN; Bisgin A; Dogan MC
    Int J Paediatr Dent; 2019 Jul; 29(4):542-548. PubMed ID: 30706587
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modeling of congenital erythropoietic porphyria by RNA interference: a new tool for preclinical gene therapy evaluation.
    Robert-Richard E; Lalanne M; Lamrissi-Garcia I; Guyonnet-Duperat V; Richard E; Pitard V; Mazurier F; Moreau-Gaudry F; Ged C; de Verneuil H
    J Gene Med; 2010 Aug; 12(8):637-46. PubMed ID: 20586119
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effective gene therapy of mice with congenital erythropoietic porphyria is facilitated by a survival advantage of corrected erythroid cells.
    Robert-Richard E; Moreau-Gaudry F; Lalanne M; Lamrissi-Garcia I; Cario-André M; Guyonnet-Dupérat V; Taine L; Ged C; de Verneuil H
    Am J Hum Genet; 2008 Jan; 82(1):113-24. PubMed ID: 18179890
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic correction of congenital erythropoietic porphyria by retrovirus-mediated gene transfer into Epstein-Barr virus-transformed B-cell lines.
    Moreau-Gaudry F; Mazurier F; Bensidhoum M; Ged C; de Verneuil H
    Blood; 1995 Mar; 85(6):1449-53. PubMed ID: 7888667
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Late onset erythropoietic porphyria (Gunther's disease).
    Rao SU; Dar NR; Abbas M; Mumtaz J
    J Coll Physicians Surg Pak; 2011 Sep; 21(9):564-6. PubMed ID: 21914417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematopoietic stem cell transplant for erythropoietic porphyrias in pediatric patients.
    Wang YM; Gloude NJ; Davies SM; Lucky AW; Nelson AS
    Pediatr Blood Cancer; 2021 Sep; 68(9):e29231. PubMed ID: 34245225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosis and management of the erythropoietic porphyrias.
    Murphy GM
    Dermatol Ther; 2003; 16(1):57-64. PubMed ID: 12919128
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lentivirus-mediated gene transfer of uroporphyrinogen III synthase fully corrects the porphyric phenotype in human cells.
    Géronimi F; Richard E; Lamrissi-Garcia I; Lalanne M; Ged C; Redonnet-Vernhet I; Moreau-Gaudry F; de Verneuil H
    J Mol Med (Berl); 2003 May; 81(5):310-20. PubMed ID: 12721665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.